Rodrigues, Stephen Fernandes de Paula 
; Fiel, Luana Almeida; Shimada, Ana Lucia; Pereira, Natalia R; Guterres, Sílvia Stanisçuaski; Pohlmann, Adriana Raffin; Farsky, Sandra Helena Poliselli
Source: Journal of Biomedical Nanotechnology. Unidade: FCF
Subjects: MICROCIRCULAÇÃO, PROTEÍNAS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Stephen Fernandes de Paula et al. Lipid-Core nanocapsules act as a drug shuttle through the blood brain barrier and reduce Glioblastoma after intravenous or oral administration. Journal of Biomedical Nanotechnology, v. 12, n. 5, p. 986-1000, 2016Tradução . . Disponível em: https://doi.org/10.1166/jbn.2016.2215. Acesso em: 10 nov. 2024.APA
Rodrigues, S. F. de P., Fiel, L. A., Shimada, A. L., Pereira, N. R., Guterres, S. S., Pohlmann, A. R., & Farsky, S. H. P. (2016). Lipid-Core nanocapsules act as a drug shuttle through the blood brain barrier and reduce Glioblastoma after intravenous or oral administration. Journal of Biomedical Nanotechnology, 12( 5), 986-1000. doi:10.1166/jbn.2016.2215NLM
Rodrigues SF de P, Fiel LA, Shimada AL, Pereira NR, Guterres SS, Pohlmann AR, Farsky SHP. Lipid-Core nanocapsules act as a drug shuttle through the blood brain barrier and reduce Glioblastoma after intravenous or oral administration [Internet]. Journal of Biomedical Nanotechnology. 2016 ; 12( 5): 986-1000.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1166/jbn.2016.2215Vancouver
Rodrigues SF de P, Fiel LA, Shimada AL, Pereira NR, Guterres SS, Pohlmann AR, Farsky SHP. Lipid-Core nanocapsules act as a drug shuttle through the blood brain barrier and reduce Glioblastoma after intravenous or oral administration [Internet]. Journal of Biomedical Nanotechnology. 2016 ; 12( 5): 986-1000.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1166/jbn.2016.2215
